Michaelson J - Search Results

1

ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models.

Hanson A, Elpek K, Duong E, Shallberg L, Fan M, Johnson C, Wallace M, Mabry GR, Sazinsky S, Pepper L, Shu CJ, Sathyanarayanan S, Zuerndorfer S, Simpson T, Gostissa M, Briskin M, Law D, Michaelson J, Harvey CJ. Hanson A, et al. Among authors: michaelson j. PLoS One. 2020 Sep 24;15(9):e0239595. doi: 10.1371/journal.pone.0239595. eCollection 2020. PLoS One. 2020. PMID: 32970735 Free PMC article.

2

TWEAK signals through JAK-STAT to induce tumor cell apoptosis.

Chapman MS, Wu L, Amatucci A, Ho SN, Michaelson JS. Chapman MS, et al. Cytokine. 2013 Jan;61(1):210-7. doi: 10.1016/j.cyto.2012.09.020. Epub 2012 Oct 27. Cytokine. 2013. PMID: 23107828

3

Development of an Fn14 agonistic antibody as an anti-tumor agent.

Michaelson JS, Amatucci A, Kelly R, Su L, Garber E, Day ES, Berquist L, Cho S, Li Y, Parr M, Wille L, Schneider P, Wortham K, Burkly LC, Hsu YM, Joseph IB. Michaelson JS, et al. MAbs. 2011 Jul-Aug;3(4):362-75. doi: 10.4161/mabs.3.4.16090. Epub 2011 Jul 1. MAbs. 2011. PMID: 21697654 Free PMC article.

4

The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models.

Michaelson JS, Kelly R, Yang L, Zhang X, Wortham K, Joseph IB. Michaelson JS, et al. Cancer Biol Ther. 2012 Jul;13(9):812-21. doi: 10.4161/cbt.20564. Epub 2012 Jun 6. Cancer Biol Ther. 2012. PMID: 22669574

5

Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.

Xia Y, Herlitz LC, Gindea S, Wen J, Pawar RD, Misharin A, Perlman H, Wu L, Wu P, Michaelson JS, Burkly LC, Putterman C. Xia Y, et al. Among authors: michaelson js. J Am Soc Nephrol. 2015 May;26(5):1053-70. doi: 10.1681/ASN.2014030233. Epub 2014 Sep 30. J Am Soc Nephrol. 2015. PMID: 25270074 Free PMC article.

6

Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.

Michaelson JS, Demarest SJ, Miller B, Amatucci A, Snyder WB, Wu X, Huang F, Phan S, Gao S, Doern A, Farrington GK, Lugovskoy A, Joseph I, Bailly V, Wang X, Garber E, Browning J, Glaser SM. Michaelson JS, et al. MAbs. 2009 Mar-Apr;1(2):128-41. doi: 10.4161/mabs.1.2.7631. Epub 2009 Mar 11. MAbs. 2009. PMID: 20061822 Free PMC article.

7

TL.8, a new antigenic determinant of the TL system.

Salant E, Michaelson J. Salant E, et al. Among authors: michaelson j. Immunogenetics. 1990;31(5-6):410-1. doi: 10.1007/BF02115021. Immunogenetics. 1990. PMID: 1695198 No abstract available.

8

TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus.

Doerner JL, Wen J, Xia Y, Paz KB, Schairer D, Wu L, Chalmers SA, Izmirly P, Michaelson JS, Burkly LC, Friedman AJ, Putterman C. Doerner JL, et al. Among authors: michaelson js. J Invest Dermatol. 2015 Aug;135(8):1986-1995. doi: 10.1038/jid.2015.124. Epub 2015 Mar 31. J Invest Dermatol. 2015. PMID: 25826425 Free PMC article.

9

Tweak induces mammary epithelial branching morphogenesis.

Michaelson JS, Cho S, Browning B, Zheng TS, Lincecum JM, Wang MZ, Hsu YM, Burkly LC. Michaelson JS, et al. Oncogene. 2005 Apr 14;24(16):2613-24. doi: 10.1038/sj.onc.1208208. Oncogene. 2005. PMID: 15735761

10

TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.

Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS. Burkly LC, et al. Cytokine. 2007 Oct;40(1):1-16. doi: 10.1016/j.cyto.2007.09.007. Epub 2007 Nov 5. Cytokine. 2007. PMID: 17981048 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page